Recently, a delegation led by Masaki Mizuno, the president of Japan Assuwon Pharmaceutical Co., Ltd. visited Da Ren Tang under Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited. Xu Xiaoyang, Chief Strategy Officer of Tianjin Pharmaceutical Holdings Co., Ltd., and relevant personnel of Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited attended the meeting.

During this period, the delegation led by Masaki Mizuno visited the production workshop of Da Ren Tang, Tianjin Medicine Exhibition Hall and Da Ren Tang Natural and Humanities Exhibition Hall, and personally felt the profound historical and cultural heritage of Da Ren Tang and the changes and achievements of the rapid development of the enterprise and increased their confidence in further cooperation. The two sides reached a new intention on expanding business cooperation.

During their stay in Tianjin, accompanied by the company's personnel, Masaki Mizuno and his fellows also visited Anguo, the "Digital Chinese Medicine Capital", and the Anguo Pre-treatment Workshop of Da Ren Tang, and intuitively felt that the production staff of Da Ren Tang practiced the mission of inheriting and innovating traditional Chinese medicine and strictly controlled the quality of medicines with actions.

Through this negotiation and exchange, the communication and trust between enterprises and customers have been enhanced. Da Ren Tang creates value for customers with high-quality export products and precise positioning. Japanese customers have a deep understanding of Da Ren Tang products, a solid foundation for further and wider cooperation in the future has been laid.